These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 29780879)
1. Altered Cerebellar Short-Term Plasticity but No Change in Postsynaptic AMPA-Type Glutamate Receptors in a Mouse Model of Juvenile Batten Disease. Studniarczyk D; Needham EL; Mitchison HM; Farrant M; Cull-Candy SG eNeuro; 2018; 5(2):. PubMed ID: 29780879 [TBL] [Abstract][Full Text] [Related]
2. Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease. Kovács AD; Weimer JM; Pearce DA Neurobiol Dis; 2006 Jun; 22(3):575-85. PubMed ID: 16483786 [TBL] [Abstract][Full Text] [Related]
3. Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Δex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. Finn R; Kovács AD; Pearce DA Neurochem Int; 2011 May; 58(6):648-55. PubMed ID: 21315126 [TBL] [Abstract][Full Text] [Related]
4. Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease. Kovács AD; Saje A; Wong A; Ramji S; Cooper JD; Pearce DA Neuropharmacology; 2012 Oct; 63(5):769-75. PubMed ID: 22683643 [TBL] [Abstract][Full Text] [Related]
5. Abnormally increased surface expression of AMPA receptors in the cerebellum, cortex and striatum of Cln3(-/-) mice. Kovács AD; Hof C; Pearce DA Neurosci Lett; 2015 Oct; 607():29-34. PubMed ID: 26375929 [TBL] [Abstract][Full Text] [Related]
6. Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis. Grünewald B; Lange MD; Werner C; O'Leary A; Weishaupt A; Popp S; Pearce DA; Wiendl H; Reif A; Pape HC; Toyka KV; Sommer C; Geis C Elife; 2017 Nov; 6():. PubMed ID: 29135436 [TBL] [Abstract][Full Text] [Related]
7. Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease. Kovács AD; Saje A; Wong A; Szénási G; Kiricsi P; Szabó E; Cooper JD; Pearce DA Neuropharmacology; 2011; 60(2-3):405-9. PubMed ID: 20971125 [TBL] [Abstract][Full Text] [Related]
8. Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease. Kovács AD; Pearce DA Exp Neurol; 2008 Jan; 209(1):288-91. PubMed ID: 17963751 [TBL] [Abstract][Full Text] [Related]
9. Altered gene expression in the eye of a mouse model for batten disease. Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100 [TBL] [Abstract][Full Text] [Related]
10. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models. Chan CH; Mitchison HM; Pearce DA Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598 [TBL] [Abstract][Full Text] [Related]
11. Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis. Weimer JM; Benedict JW; Getty AL; Pontikis CC; Lim MJ; Cooper JD; Pearce DA Brain Res; 2009 Apr; 1266():93-107. PubMed ID: 19230832 [TBL] [Abstract][Full Text] [Related]
12. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease. Chan CH; Ramirez-Montealegre D; Pearce DA Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480 [TBL] [Abstract][Full Text] [Related]
13. Functional categorization of gene expression changes in the cerebellum of a Cln3-knockout mouse model for Batten disease. Brooks AI; Chattopadhyay S; Mitchison HM; Nussbaum RL; Pearce DA Mol Genet Metab; 2003 Jan; 78(1):17-30. PubMed ID: 12559844 [TBL] [Abstract][Full Text] [Related]
14. Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender. Kovács AD; Pearce DA Dis Model Mech; 2015 Apr; 8(4):351-61. PubMed ID: 26035843 [TBL] [Abstract][Full Text] [Related]
15. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Luiro K; Kopra O; Lehtovirta M; Jalanko A Hum Mol Genet; 2001 Sep; 10(19):2123-31. PubMed ID: 11590129 [TBL] [Abstract][Full Text] [Related]
16. Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3). Burkovetskaya M; Karpuk N; Kielian T Neurobiol Dis; 2017 Apr; 100():19-29. PubMed ID: 28042098 [TBL] [Abstract][Full Text] [Related]